Workflow
AI医疗大模型
icon
Search documents
人工智能成为第22届东博会亮眼元素
Xin Hua She· 2025-09-20 10:23
连续五年参展的土耳其商人伊纳亚特说:"今年多了很多科技和AI元素。" 杭州宏杉科技股份有限公司是一家专注于数智存储研发的国家级专精特新"小巨人"企业,今年首次参加 东博会。"随着数字时代发展,对于智能存储的需求越来越大。我们已经在金融、交通等行业广泛应 用,希望在东博会期间结识更多合作伙伴。"公司广西区域售后服务负责人陈琦说。 如今,人工智能不仅大规模应用于工厂、企业,还加速向个人生活场景渗透,在提升生活便利性、促进 医疗健康、推动政务服务智能化等方面发挥重要作用。记者在东博会人工智能专馆看到,AI正以更直 观的方式走进大众生活。 语音输入病情描述,机器人AI医疗大模型快速思考给出病因分析、建议治疗方案,甚至可以实现24小 时远程互联网医生诊疗服务……整个过程就像和一位随身医生对话。 新华社南宁9月20日电 题:人工智能成为第22届东博会亮眼元素 "越来越多的医疗机构将AI应用到医疗辅助问诊服务,如今公司抢抓广西大力发展人工智能的机遇,在 玉林投资建设子公司,依靠广西独特的区位优势出口东盟市场。"浙江孚宝智能科技有限公司副总裁党 维纳说,从日常疾病诊断、治疗方案建议,到患者护理和健康管理,人工智能正在全方位改 ...
泰达生物携手弘信电子附属公司 战略布局AI医疗健康与智算中心建设
Ge Long Hui· 2025-08-28 01:01
Core Viewpoint - The strategic cooperation agreement between Teda Biomedical and Suihong Huachuang Technology aims to leverage each other's resources, talent, and technology in the AI healthcare sector, focusing on specialized operations and market promotion [1][2] Group 1: Strategic Cooperation - Teda Biomedical has signed a strategic cooperation agreement with Suihong Huachuang Technology to enhance AI healthcare and data business operations [1] - The collaboration will focus on building intelligent computing centers and providing heterogeneous computing hardware solutions [1] - The partnership aims to ensure stable and efficient computing resources, which are crucial for the development and commercialization of AI healthcare models [1] Group 2: Resource and Technology Synergy - The agreement allows for complementary advantages in resources and technology between Teda Biomedical and Suihong Huachuang [2] - Suihong Huachuang's established government partnerships and sales channels will support Teda Biomedical's market promotion efforts for AI healthcare models [2] - The core technological capabilities of Suihong Huachuang in computing infrastructure and hardware manufacturing will provide stable computing support and cost-effective solutions for Teda Biomedical [2]
泰达生物(08189.HK)携手弘信电子附属公司 战略布局AI医疗健康与智算中心建设
Ge Long Hui· 2025-08-28 00:21
Core Viewpoint - The strategic cooperation agreement between Teda Biomedical and Suihong Huachuang Technology aims to leverage each other's resources and technological advantages in the AI healthcare sector, focusing on specialized operations and market promotion of AI medical health and data businesses [1][2]. Group 1: Strategic Cooperation - The partnership will enhance resource and technology synergies, utilizing Suihong Huachuang's established government collaborations and sales channels to support Teda Biomedical's AI medical model and related data business market promotion [2]. - Suihong Huachuang's core technological capabilities in AI computing infrastructure and hardware manufacturing will provide stable and efficient computing power for Teda Biomedical's AI medical model training and real-world application [2]. Group 2: Business Development Focus - Teda Biomedical is actively advancing the research and commercialization of AI medical models and related data businesses, emphasizing the importance of high-quality computing resources, stable hardware solutions, and extensive market promotion channels [1]. - The company plans to engage in resource alignment and cooperation discussions to ensure the sustainable and steady advancement of its business [1].
泰达生物(08189)与燧弘华创签署AI医疗健康领域战略合作协议
智通财经网· 2025-08-27 12:55
Core Viewpoint - The strategic cooperation agreement between Teda Bio and Shanghai Suihonghuachuang Technology Co., Ltd. aims to leverage their respective resources, talents, and technological advantages in the AI healthcare sector, focusing on specialized operations and market promotion [1][2]. Group 1: Strategic Cooperation - The partnership will enhance resource and technology synergies, utilizing Suihonghuachuang's established government collaborations and sales channels to support Teda Bio's AI healthcare model and data business market promotion [2]. - The collaboration will provide stable and efficient computing power and cost-effective hardware solutions, which are crucial for optimizing AI healthcare model training and facilitating commercial application [2]. Group 2: Business Development Focus - Teda Bio is actively advancing its AI healthcare model and related data business, emphasizing the importance of high-quality computing resources, stable hardware solutions, and extensive market promotion channels for effective business development [1]. - The company plans to engage in resource alignment and cooperation discussions to ensure sustainable and robust business growth [1].
泰达生物附属医数精诚与深算院签署生态合作协议
Zhi Tong Cai Jing· 2025-08-11 15:31
Core Viewpoint - The company is enhancing its AI medical model business through a strategic partnership with Shenzhen Computing Science Research Institute, focusing on high-quality medical data for training and application [1][2] Group 1: Partnership and Collaboration - The company’s subsidiary, Shenzhen Yishuzhengcheng Technology Co., Ltd., has signed an ecological cooperation agreement with Shenzhen Computing Science Research Institute [1] - The collaboration aims to leverage each party's resources, talent, and technological advantages in database, data quality, and data analysis [1][2] Group 2: AI Medical Model Development - The company is actively developing AI medical models, which require high-quality, secure, and available medical big data as core support [1] - Medical data includes diverse forms such as medical records, imaging, and test reports, necessitating precise data cleaning and annotation [1] Group 3: Strategic Goals - The board believes that the partnership will create a closed-loop ecosystem of "data governance + model iteration + scenario implementation" [2] - This integration will enable the company to provide comprehensive data services, including data cleaning, intelligent analysis, and customized model training for various clients [2] - High-quality data and precise analytical capabilities are expected to accelerate the optimization and commercialization of the company's AI medical models, enhancing its core competitiveness in the AI healthcare sector [2]
泰达生物(08189.HK)拟携手深算院在数据库、数据质量和数据分析价值方面的研发和市场应用形成深度合作
Ge Long Hui· 2025-08-11 14:13
Core Viewpoint - The company has signed an ecological cooperation agreement with Shenzhen Computing Science Research Institute to enhance its AI medical model business through collaboration in data quality and analysis [1][2] Group 1: Strategic Cooperation - The agreement aims to leverage the advanced technologies developed by the Shenzhen Computing Science Research Institute in database systems, data quality systems, and data analysis systems [2] - The collaboration will create a closed-loop ecosystem of "data governance + model iteration + scenario implementation" [2] - This partnership is expected to provide comprehensive data services, including data cleaning, intelligent analysis, and customized model training for clients in the healthcare sector, government departments, and industry AI applications [2] Group 2: AI Medical Model Development - The company is focusing on the development of AI medical models, which require high-quality, secure, and available medical big data as core support [1] - The medical data encompasses various forms such as medical records, imaging, and laboratory reports, necessitating high precision in data cleaning and labeling [1] - The collaboration is anticipated to accelerate the optimization and commercialization of the company's AI medical models, enhancing its core competitiveness in the AI healthcare sector [2]
泰达生物(08189)附属医数精诚与深算院签署生态合作协议
智通财经网· 2025-08-11 13:49
Core Viewpoint - The company has signed an ecological cooperation agreement with Shenzhen Computing Science Research Institute to enhance its AI medical model business through collaboration in data quality and analysis [1][2] Group 1: Strategic Partnership - The partnership aims to leverage each party's resources, talent, and technological advantages for deep cooperation in database, data quality, and data analysis [1] - The agreement will integrate cutting-edge technologies developed by the research institute in database systems, data quality systems, and data analysis systems [2] Group 2: AI Medical Model Development - The company is focusing on the development of AI medical models, which require high-quality, secure, and available medical big data as core support [1] - The collaboration will enable the company to provide a full-process service covering data cleaning, intelligent analysis, and customized model training for various clients, including medical institutions and government departments [2] Group 3: Competitive Advantage - By utilizing high-quality data and precise analytical capabilities, the company aims to accelerate the optimization and commercialization of its AI medical models [2] - This strategic move is expected to strengthen the company's core competitiveness in the AI medical sector [2]
润达医疗(603108):医疗点评:AI+医疗加速落地,主业经营逐步改善
ZHESHANG SECURITIES· 2025-08-06 13:44
Investment Rating - The investment rating for the company is "Buy" [5] Core Insights - The company's main business is gradually improving, with a reduction in losses reported for Q2. The estimated net profit for Q2 is projected to be between -0.61 billion to -0.39 billion CNY, narrowing the loss compared to Q1 by 0.08 billion to 0.30 billion CNY [1] - The company has partnered with Huawei to enter the overseas market, developing an AI medical model that received top scores in MedBench evaluations. Their AI medical solution integrates a clinical decision-making system that enhances trust in generative AI within the medical field [2] - The establishment of a national AI medical application pilot base is underway, focusing on clinical research and addressing industry pain points. This initiative is supported by various local governments, promoting the development of AI-assisted diagnostic and treatment products [3] Financial Forecast and Valuation - The revenue forecast for the company from 2025 to 2027 is projected to reach 78.25 billion, 87.76 billion, and 102.25 billion CNY, with year-on-year growth rates of -5.86%, +12.16%, and +16.51% respectively. The net profit for the same period is expected to be -0.75 billion, 3.02 billion, and 4.45 billion CNY, with growth rates of -235.19%, +504.23%, and +47.24% respectively. The estimated P/E ratio for 2026 is 39 times [4][10]
政观长三角|科创聚势,风起临平
Xin Lang Cai Jing· 2025-06-24 07:00
Core Viewpoint - Linping District in Hangzhou is transforming into a hub for technological innovation and advanced manufacturing, aiming to become a model for common prosperity and a highland for digital transformation in the Yangtze River Delta region [1][14]. Group 1: Technological Innovation - Linping has seen significant growth in technological innovation, with 24 enterprises recognized as provincial-level R&D institutions, including 5 key enterprise research institutes, ranking first in the province [1]. - The district's R&D investment accounted for 3.79% of its GDP, with 1,498 new invention patents filed, marking a 60.6% increase [15]. - Linping has added 3 new "little giant" enterprises and 12 national-level specialized "little giant" enterprises [1][15]. Group 2: Industry Development - The China (Hangzhou) Computing Power Town, the first of its kind in the country, has attracted over 2,400 companies across various sectors, including AI algorithms, chip design, and software services [4]. - The Computing Power Town hosts 50 national high-tech enterprises and 127 provincial technology-based SMEs, benefiting from the surge in artificial intelligence [4]. - The establishment of the Hangzhou Data Element Operation Center in the Computing Power Town aims to create a collaborative innovation center for data elements [11]. Group 3: Policy Support and Ecosystem - Linping offers a comprehensive policy support system for enterprises, including rent reductions, R&D subsidies, and talent introduction, facilitating growth from startup to maturity [8]. - The district has implemented a one-stop service center that provides 100% coverage for enterprise needs, including talent recruitment and financial connections [11]. - Companies like Mude Micro-Nano and Zhizhen Technology have benefited from local policies, enabling them to innovate and reduce operational costs significantly [8][10]. Group 4: Strategic Location - Linping serves as a natural "bridgehead" for Hangzhou's integration with Shanghai and the Yangtze River Delta, supported by a well-developed transportation network [12]. - The district is strategically located at the intersection of major innovation corridors, enhancing its role in regional economic development [12][14]. Group 5: Future Outlook - Linping is expected to continue attracting innovative enterprises, with over 100 companies in the artificial intelligence sector already established [14]. - The district's focus on digital economy and intelligent manufacturing positions it as a key player in the future industrial landscape of Hangzhou and the Yangtze River Delta [16].